(Q45399119)

English

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.

scientific article published in December 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Murat Akyildiz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Zeki Karasu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Murat Zeytunlu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Unal Aydin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tijen Ozacar

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2130-2134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Prevention of recurrent hepatitis B post-liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Treatment of recurrent hepatitis B infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Management of HBV Infection in Liver Transplantation Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Management of hepatitis B in liver transplantation patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Treatment of fibrosing cholestatic hepatitis with lamivudine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04609.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2006.04609.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18031370%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45399119&oldid=1584897304"